Thomas A. Mitro
2013
In 2013, Thomas A. Mitro earned a total compensation of $3.3M as President & Chief Operating Officer at Aerie Pharmaceuticals.
Compensation breakdown
| Bonus | $30,686 |
|---|---|
| Option Awards | $3,098,654 |
| Salary | $140,279 |
| Other | $40,000 |
| Total | $3,309,619 |
Mitro received $3.1M in option awards, accounting for 94% of the total pay in 2013.
Mitro also received $30.7K in bonus, $140.3K in salary and $40K in other compensation.
Rankings
In 2013, Thomas A. Mitro's compensation ranked 2,244th out of 12,286 executives tracked by ExecPay. In other words, Mitro earned more than 81.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,244 out of 12,286 | 82nd |
Division Manufacturing | 741 out of 4,612 | 84th |
Major group Chemicals And Allied Products | 201 out of 1,462 | 86th |
Industry group Drugs | 134 out of 1,156 | 88th |
Industry Biological Products, Except Diagnostic Substances | 18 out of 196 | 91st |
Source: SEC filing on February 27, 2015.
Mitro's colleagues
We found four more compensation records of executives who worked with Thomas A. Mitro at Aerie Pharmaceuticals in 2013.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019